2-(1,1-Dioxo-1,2-thiazinan-2-yl)pyrimidine-5-carboxylic acid, >95%, 1g

2-((Triisopropylsilyl)oxy)acetohydrazide, 98%, 1g

1-Cyclohexyl-2-(5H-imidazo[5,1-a]isoindol-5-yl)ethanol, 95.0%, 250mg

2-Bromo-3,4-dimethoxybenzaldehyde, 95.0%, 1g

Adamantan-1-yl(cyclohexyl)(2',4',6'-triisopropyl-3,6-dimethoxy-[1,1'-biphenyl]-2-yl)phosphane, 1g

(+)-DIPIVALOYL-D-TARTARIC ACID, 98.0%, 5g

1-Methyl-1H-pyrazole-4-carboxylic acid, 97.0%, 5g

(R)-2-(4-((2-Aminobutyl)amino)pyrimidin-2-yl)-4-(1-methyl-1H-pyrazol-4-yl)phenol dihydrochloride, 98+%, 25mg

BICYCLO[3.1.0]HEXANE-3-CARBOXYLIC ACID, 95.0%, 5g

4-(2-Chloro-phenyl)-3-oxo-butyric acid ethyl ester, 2g

Buffer solution pH 4.00 ±0.02 (20 °C), ROTI®Calipure ready to use, 10 l, plastic packaging.

N4-(3-Ethynylphenyl)-7-methoxyquinazoline-4,6-diamine, 95.0%, 100mg

1-(Trifluoromethanesulfonyl)imidazole, 97.0%, 1g